IKK-β mediates chemoresistance by sequestering FOXO3; a critical factor for cell survival and death

Tugsan Tezil1, Cagri Bodur, Ozgur Kutuk

  • 1Sabanci University, Biological Sciences and Bioengineering Program, 34956, Tuzla, Istanbul, Turkey. teziltugsan@su.sabanciuniv.edu

Cellular Signalling
|February 9, 2012
PubMed

Insights

FOXO3 enhances cisplatin sensitivity in breast cancer cells. Inhibitor IKK-beta blocks FOXO3, promoting chemoresistance by preventing nuclear localization and apoptosis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Chemotherapy resistance in breast cancer is a significant clinical challenge, often linked to cell-type-specific mechanisms.
  • The transcription factor FOXO3 regulates genes involved in cell death, but its precise role in chemoresistance remains unclear.

Purpose of the Study:

  • To investigate the role of FOXO3 in mediating cisplatin chemosensitivity in breast cancer.
  • To elucidate the mechanism by which IKK-beta influences FOXO3 activity and chemoresistance.

Main Methods:

  • Utilized MCF-7 (high FOXO3) and MDA-MB-231 (low FOXO3) breast cancer cell lines.
  • Employed RNA interference to assess FOXO3-dependent apoptosis induction by cisplatin.
  • Investigated the interaction between IKK-beta and FOXO3 using cisplatin treatment and overexpression models.

Main Results:

  • FOXO3 critically mediates cisplatin-induced apoptosis in MCF-7 cells.
  • IKK-beta inhibits FOXO3 nuclear localization and function in MDA-MB-231 cells, promoting chemoresistance.
  • Cisplatin treatment in FOXO3-overexpressing MDA-MB-231 cells led to autophagosome formation and inhibited caspase cleavage.

Conclusions:

  • FOXO3 levels and activity are crucial determinants of cisplatin chemosensitivity in breast cancer.
  • IKK-beta promotes chemoresistance by sequestering FOXO3 in the cytosol, hindering its pro-apoptotic function.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...